Coactivators and nuclear receptor transactivation

Journal of Cellular Biochemistry

Volumn 104, Issue 5, 2008, Pages 1580-1586

  Wolf, Irene M ^a   Heitzer, Marjet D ^a   Grubisha, Melanie ^a   DeFranco, Donald B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chromatin; Coactivator; Histone; Nuclear receptor; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; CHAPERONE; CHOLECYSTOKININ OCTAPEPTIDE[28,31 N METHYLNORLEUCINE]; COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; HISTONE; HOP PROTEIN; METHYLTRANSFERASE; NUCLEAR RECEPTOR COACTIVATOR 2; P23 PROTEIN; PROTEASOME; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN SWI; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TAMOXIFEN; UNCLASSIFIED DRUG;

BREAST CANCER; CELL TYPE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DNA MODIFICATION; ENZYME SUBUNIT; GENE ACTIVITY; GENETIC ANALYSIS; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; REVIEW; RNA SPLICING; RUBINSTEIN SYNDROME; TISSUE SPECIFICITY; TISSUE TYPES; TRANSACTIVATION; TRANSCRIPTION REGULATION; UBIQUITINATION;

ANIMALS; DISEASE; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 50249090941     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21755     Document Type: Review

References (49)

1. Aiyar SE, Sun JL, Blair AL, Moskaluk CA, Lu YZ, Ye QN, Yamaguchi Y, Mukherjee A, Ren DM, Handa H, Li R. 2004. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev 18:2134-2146.
2. Andersson U, Scarpulla RC. 2001. Pgc-1-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells. Mol Cell Biol 21:3738-3749.
3. Aoyagi S, Trotter KW, Archer TK. 2005. ATP-dependent chromatin remodeling complexes and their role in nuclear receptor-dependent transcription in vivo. Vitam Horm 70:281-307.
4. Auboeuf D, Batsche E, Dutertre M, Muchardt C, O'Malley BW. 2007. Coregulators: Transducing signal from transcription to alternative splicing. Trends Endocrinol Metab 18:122-129.
5. Auger AP, Tetel MJ, McCarthy MM. 2000. Steroid receptor coactivator-1 (SRC-1) mediates the development of sex-specific brain morphology and behavior. Proc Natl Acad Sci USA 97:7551-7555.
6. Belandia B, Orford RL, Hurst HC, Parker MG. 2002. Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO J 21:4094-4103.
7. Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, StaUcup MR. 1999. Regulation of transcription by a protein methyltransferase. Science 284: 2174-2177.
8. Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM. 2007. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 120:719-733.
9. Corey LL, Weirich CS, Benjamin IJ, Kingston RE. 2003. Localized recruitment of a chromatin-remodeling activity by an activator in vivo drives transcriptional elongation. Genes Dev 17:1392-1401.
10. de la Mata M, Alonso CR, Kadener S, Fededa JP, Blaustein M, Pelisch F, Cramer P, Bentley D, Kornblihtt AR. 2003. A slow RNA polymerase II affects alternative splicing in vivo. Mol Cell 12:525-532.
11. Elkin M, Orgel A, Kleinman HK. 2004. An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst 96:875-878.
12. Fryer CJ, Nordeen SK, Archer TK. 1998. Antiprogestins mediate differential effects on glucocorticoid receptor remodeling of chromatin structure. J Biol Chem 273: 1175-1183.
13. Gao Z, Schwartz LM. 2005. Identification and analysis of Hic-5/ARA55 isoforms: Implications for integrin signaling and steroid hormone action. FEBS Lett 579:5651-5657.
14. Ge K, Guermah M, Yuan CX, Ito M, Wallberg AE, Spiegelman BM, Roeder RG. 2002. Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature 417:563-567.
15. Gehin M, Mark M, Dennefeld C, Dierich A, Gronemeyer H, Chambon P. 2002. The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol Cell Biol 22:5923-5937.
16. Glass CK, Rose DW, Rosenfeld MG. 1997. Nuclear receptor coactivators. Curr Opin Cell Biol 9:222-232.
17. Goldstrohm AC, Greenleaf AL, Garcia-Blanco MA. 2001. Co-transcriptional splicing of pre-messenger RNAs: Considerations for the mechanism of alternative splicing. Gene 277:31-47.
18. Han SJ, DeMayo FJ, Xu J, Tsai SY, Tsai MJ, O'Malley BW. 2006. Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol Endocrinol 20:45-55.
19. Heitzer MD, DeFranco DB. 2006. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. Mol Endocrinol 20:56-64.
20. Ichinose H, Garnier JM, Chambon P, Losson R. 1997. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. Gene 188:95-100.
21. Ito M, Okano HJ, Darnell RB, Roeder RG. 2002. The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development. EMBO J 21:3464-3475.
22. Jenuwein T, Allis CD. 2001. Translating the histone code. Science 293:1074-1080.
23. Kalkhoven E, Roelfsema JH, Teunissen H, den Boer A, Ariyurek Y, Zantema A, Breuning MH, Hennekam RC, Peters DJ. 2003. Loss of CBP acetyltransferase activity by PHD finger mutations in Rubinstein-Taybi syndrome. Hum Mol Genet 12:441-450.
24. Kang YK, Guermah M, Yuan CX, Roeder RG. 2002. The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. Proc Natl Acad Sci USA 99:2642-2647.
25. Lee DK, Duan HO, Chang C. 2001. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. J Biol Chem 276:9978-9984.
26. Lonard DM, O'malley BW. 2007. Nuclear receptor coregulators: Judges, juries, and executioners of cellular regulation. Mol Cell 27:691-700.
27. Lonard DM, Lanz RB, O'Malley BW. 2007. Nuclear receptor coregulators and human disease. Endocr Rev 28:575-587.
28. McNally JG, Muller WG, Walker D, Wolford R, Hager GL. 2000. The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells. Science 287:1262-1265.
29. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F. 2003. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763.
30. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D, Chambon P. 1989. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57: 433-442.
31. Monsalve M, Wu Z, Adelmant G, Puigserver P, Fan M, Spiegelman BM. 2000. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol Cell 6:307-316.
32. Onate SA, Tsai SY, Tsai MJ, O'Malley BW. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357.
33. Pascual-Le Tallec L, Lombes M. 2005. The mineralocorticoid receptor: A journey exploring its diversity and specificity of action. Mol Endocrinol 19:2211-2221.
34. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116: 511-526.
35. Pratt WB, Galigniana MD, Harrell JM, DeFranco DB. 2004. Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell Signal 16:857-872.
36. Roeder RG. 1996. Nuclear RNA polymerases: Role of general initiation factors and cofactors in eukaryotic transcription. Methods Enzymol 273:165-171.
37. Roelfsema JH, White SJ, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen GJ, Breuning MH, Hennekam RC, Peters DJ. 2005. Genetic heterogeneity in Rubinstein-Taybi syndrome: Mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet 76:572-580.
38. Rosenfeld MG, Lunyak W, Glass CK. 2006. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20:1405-1428.
39. Savkur RS, Burris TP. 2004. The coactivator LXXLL nuclear receptor recognition motif. J Pept Res 63:207-212.
40. Shang Y, Brown M. 2002. Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468.
41. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852.
42. Shilatifard A. 1998. Factors regulating the transcriptional elongation activity of RNA polymerase II. FASEB J 12: 1437-1446.
43. Shilatifard A. 2006. Chromatin modifications by methyl-ation and ubiquitination: Implications in the regulation of gene expression. Annu Rev Biochem 75:243-269.
44. Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, Schiff R. 2004. Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. J Natl Cancer Inst 96:926-935.
45. Winnay JN, Xu J, O'Malley BW, Hammer GD. 2006. Steroid receptor coactivator-1-deficient mice exhibit altered hypothalamic-pituitary-adrenal axis function. Endocrinology 147:1322-1332.
46. Wu RC, Qin J, Yi P, Wong J, Tsai SY, Tsai MJ, O'Malley BW. 2004. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic responses to multiple cellular signaling pathways. Mol Cell 15:937-949.
47. Wu RC, Feng Q, Lonard DM, O'Malley BW. 2007. SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock. Cell 129:1125-1140.
48. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C, O'Malley BW. 2000. The steroid receptor coactivator SRC-3 (p/CIP/ RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc Natl Acad Sci USA 97:6379-6384.
49. Yang L, Guerrero J, Hong H, DeFranco DB, Stallcup MR. 2000. Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol Biol Cell 11: 2007-2018.